Sequential combination chemotherapy of advanced head and neck carcinoma: re-evaluation of a highly effective regimen

Strahlentherapie. 1981 Apr;157(4):277-9.

Abstract

Twenty-seven evaluable patients with advanced head and neck squamous carcinoma were treated with a polychemotherapeutic regimen described in 1975 by Price et al. Chemotherapy consisted of vincristine, adriamycin, bleomycin, methotrexate, 5-fluorouracil, hydroxyurea, 6-mercaptopurine and citrovorum factor administered sequentially. One complete remission, 4 partial remissions, 7 minor responses were obtained for a total of 12/77 (44%) objective responses. Toxicity was acceptable. The results obtained were not better than those observed with less complicated regimens administrable on an outpatient basis.

MeSH terms

  • Adult
  • Aged
  • Bleomycin / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy
  • Doxorubicin / therapeutic use
  • Female
  • Fluorouracil / therapeutic use
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Hydroxyurea / therapeutic use
  • Leucovorin / therapeutic use
  • Male
  • Mercaptopurine / therapeutic use
  • Methotrexate / therapeutic use
  • Middle Aged
  • Vincristine / therapeutic use

Substances

  • Bleomycin
  • Vincristine
  • Doxorubicin
  • Mercaptopurine
  • Leucovorin
  • Fluorouracil
  • Hydroxyurea
  • Methotrexate